Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Julphar
Harvard Business School
McKesson
Johnson and Johnson
Accenture
Cerilliant
Mallinckrodt

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,119,148

« Back to Dashboard

Which drugs does patent 8,119,148 protect, and when does it expire?

Patent 8,119,148 protects TRILEPTAL and is included in one NDA.

Protection for TRILEPTAL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has forty-three patent family members in thirty-three countries.
Summary for Patent: 8,119,148
Title:Suspension comprising oxcarbazepine
Abstract: This invention provides a pharmaceutical composition in the form of a suspension comprising oxcarbazepine.
Inventor(s): Sigg; Juergen (Loerrach, DE), Billington; Michael (Riehen, CH)
Assignee: Novartis Pharmaceuticals Corporation (East Hanover, NJ)
Application Number:10/168,248
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 8,119,148

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis TRILEPTAL oxcarbazepine SUSPENSION;ORAL 021285-001 May 25, 2001 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,119,148

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9930058.4Dec 20, 1999
PCT Information
PCT FiledDecember 19, 2000PCT Application Number:PCT/EP00/12968
PCT Publication Date:June 28, 2001PCT Publication Number: WO01/45671

International Patents Family Members for US Patent 8,119,148

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 030175 ➤ Try a Free Trial
Austria 269694 ➤ Try a Free Trial
Australia 2511801 ➤ Try a Free Trial
Australia 777619 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
Healthtrust
McKesson
Accenture
Federal Trade Commission
McKinsey
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.